Figure 1.
The microscopic identification results of enriched cervical cancer CTCs and white blood cells (WBCs) performed by immune fluorescence in situ hybridization. A: DAPI+, blue; B, CEP8+, orange; C, CD45+, red; D, merge (CEP8 signal point ≥ 3, count as positive; CEP8 signal point≤2, count as negative);(1a) Identification of CTCs: DAPI+ / CEP8+ / CD45-. (1b) Identification of WBCs: DAPI+ / CEP8- / CD45+.
